Powered by: Motilal Oswal
2025-03-09 09:23:35 am | Source: Choice Broking
Buy Coforge Limited For the Target Rs. 11,260 - Choice Broking Ltd
Buy Coforge Limited For the Target Rs.  11,260 - Choice Broking Ltd

Assessing Q3 Results in Light of Recent Acquisitions & Deal Wins

Fresh order intake and $1.56Bn Sabre collaboration to propel revenue towards $2Bn milestone: Coforge has secured its largest deal, a 13-year, $1.56Bn partnership with Sabre, potentially boosting its revenue by $100- $120Mn annually along with on-going revenue growth, which is projected to add approximately 8-10% to the current revenue levels. This agreement makes Coforge a key player in Sabre's efforts to enhance product delivery and implement AI-driven solutions. In addition to this, Coforge demonstrated strong momentum in Q3FY25 with a fresh order intake of $501Mn, including four major deals across North America and ASEAN, one within the Cigniti client portfolio. Management remains optimistic about future deal wins, citing a substantial deal pipeline. Considering this, we anticipate that Coforge medium-term revenue guidance of hitting $2Bn mark remains on track and expected to achieve sooner this makes Coforge a serious contender against Tier – I companies to grab mega deals.

Acquisition of Rythmos Inc. and TMLabs Pty Ltd to boost cloud and ServiceNow expertise: Coforge is expanding its portfolio through the acquisition of two IT/ITeS companies: Rythmos Inc. and TMLabs Pty Ltd. Coforge will acquire 100% stakes in both firms. Rythmos, operating in the US and India, will be acquired for $30Mn upfront, with an additional $18.7Mn possible based on specific performance conditions. Rythmos is expected to generate $ 25.3Mn in turnover for the year 2024 and maintain a similar growth trajectory. With a favorable valuation of 1.9x of its revenue, this acquisition will enhance Coforge’s data, cloud, and airline industry expertise. TMLabs, based in Australia, will be acquired for $20Mn to boost Coforge’s ServiceNow capabilities, generating a turnover of $ 11Mn for the FY ending June2024. TMLabs has demonstrated strong growth, with 25% CAGR from FY22 to FY24 and is expected to contribute at similar lines going forward. Both deals are expected to close by Q4FY25.

Q3FY25 Performance: Coforge's Q3FY25 revenue exceeded estimates, while EBIT met expectations, but PAT missed expectations. Revenue was INR 33.1Bn, up 42.8% YoY and 8.4% QoQ, surpassing the INR 31.4Bn consensus estimates. EBIT stood at INR 3.9Bn, up 22.5% YoY and 9.0% QoQ, in line with expectations. However, the EBIT margin declined by 196bps YoY but rose by 7bps QoQ to 11.8%, slightly below the 12.1% consensus estimates. PAT was INR 2.1Bn, down 9.5% YoY but up 6.6% QoQ, missing the INR 2.6Bn consensus estimates

View and valuation: With recent acquisitions and significant deal wins, the company remains focused on driving strong growth across its various business segments, both in the short and long term. We project Revenue/EBIT/PAT to grow at a CAGR of 24.4%/ 35.1%/ 48.6% respectively over FY25E-FY27E. As a result, we upgrade our rating to BUY to arrive at a revised target price of INR11,260 implying a P/E of 40 on FY27E EPS of INR281.5.

 

For Detailed Report With Disclaimer Visit. https://choicebroking.in/disclaimer
SEBI Registration no.: INZ 000160131

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here